.10+ cents coming quickly this week; so many news eyes introduced to RXMD over the past few days.
We have an undervalued, highly productive and a laser focused company dedicated to success. Failure has never been an option for Ms. Mars; she's has to be one of the highest quality CEOs I have ever witnessed on the OTC.